Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011;16(10):1347-8.
doi: 10.1634/theoncologist.2011-0312.

Self-plagiarism

Bruce A Chabner
Editorial

Self-plagiarism

Bruce A Chabner. Oncologist. 2011.

Abstract

The background and explanation for the retraction of Brian Rini's article from the March 2005 issue of The Oncologist are provided.

PubMed Disclaimer

Comment on

  • Retraction.
    [No authors listed] [No authors listed] Oncologist. 2011;16(10):1481. doi: 10.1634/theoncologist.10-3-191.retraction. Oncologist. 2011. PMID: 22016497 Free PMC article. No abstract available.

References

    1. Rini BI. VEGF–targeted therapy in metastatic renal cell carcinoma. The Oncologist. 2005;10:191–197. - PubMed
    1. Rini BI, Small EJ. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma. J Clin Oncol. 2005;23:1028–1043. - PubMed
    1. Rini BI, Sosman JA, Motzer RJ. Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: Biology, clinical results and future development. BJU Int. 2005;96:286–290. - PubMed
    1. Rathmell WK, Wright TM, Rini BI. Molecularly targeted therapy in renal cell carcinoma. Expert Rev Anticancer Ther. 2005;5:1031–1040. - PubMed
    1. Choueiri TK, Bukowski RM, Rini BI. The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma. Semin Oncol. 2006;33:596–606. - PubMed